Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Julie Goodman to Animals

This is a "connection" page, showing publications Julie Goodman has written about Animals.

 
Connection Strength
 
 
 
0.473
 
  1. Marchitti SA, Boon D, Jack M, Goodman JE. Lack of Genotoxic and Carcinogenic Potential for Nonsugar Sweeteners: A Review of Animal and Mechanistic Evidence. Adv Nutr. 2025 Dec; 16(12):100552.
    View in: PubMed
    Score: 0.048
  2. Prueitt RL, Drury NL, Shore RA, Boon DN, Goodman JE. Talc and human cancer: a systematic review of the experimental animal and mechanistic evidence. Crit Rev Toxicol. 2024 Jul; 54(6):359-393.
    View in: PubMed
    Score: 0.044
  3. Prueitt RL, Goodman JE. Evidence evaluated by European Food Safety Authority does not support lowering the temporary tolerable daily intake for bisphenol A. Toxicol Sci. 2024 03 26; 198(2):185-190.
    View in: PubMed
    Score: 0.043
  4. Prueitt RL, Hixon ML, Fan T, Olgun NS, Piatos P, Zhou J, Goodman JE. Systematic review of the potential carcinogenicity of bisphenol A in humans. Regul Toxicol Pharmacol. 2023 Aug; 142:105414.
    View in: PubMed
    Score: 0.040
  5. Lynch HN, Prueitt RL, Goodman JE. Critique of the ACGIH 2016 derivation of toluene diisocyanate Threshold Limit Values. Regul Toxicol Pharmacol. 2018 Aug; 97:189-196.
    View in: PubMed
    Score: 0.029
  6. Goodman JE, Zu K, Loftus CT, Lynch HN, Prueitt RL, Mohar I, Shubin SP, Sax SN. Short-term ozone exposure and asthma severity: Weight-of-evidence analysis. Environ Res. 2018 01; 160:391-397.
    View in: PubMed
    Score: 0.028
  7. Prueitt RL, Lynch HN, Zu K, Shi L, Goodman JE. Dermal exposure to toluene diisocyanate and respiratory cancer risk. Environ Int. 2017 12; 109:181-192.
    View in: PubMed
    Score: 0.027
  8. Zu K, Pizzurro DM, Lewandowski TA, Goodman JE. Pharmacokinetic data reduce uncertainty in the acceptable daily intake for benzoic acid and its salts. Regul Toxicol Pharmacol. 2017 Oct; 89:83-94.
    View in: PubMed
    Score: 0.027
  9. Lynch HN, Loftus CT, Cohen JM, Kerper LE, Kennedy EM, Goodman JE. Weight-of-evidence evaluation of associations between particulate matter exposure and biomarkers of lung cancer. Regul Toxicol Pharmacol. 2016 Dec; 82:53-93.
    View in: PubMed
    Score: 0.026
  10. Prueitt RL, Cohen JM, Goodman JE. Evaluation of atherosclerosis as a potential mode of action for cardiovascular effects of particulate matter. Regul Toxicol Pharmacol. 2015 Nov 15; 73(2 Suppl):S1-15.
    View in: PubMed
    Score: 0.024
  11. Prueitt RL, Rhomberg LR, Goodman JE. Hypothesis-based weight-of-evidence evaluation of the human carcinogenicity of toluene diisocyanate. Crit Rev Toxicol. 2013 May; 43(5):391-435.
    View in: PubMed
    Score: 0.020
  12. Rhomberg LR, Goodman JE. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made? Regul Toxicol Pharmacol. 2012 Oct; 64(1):130-3.
    View in: PubMed
    Score: 0.019
  13. Goodman JE, Prueitt RL, Thakali S, Oller AR. The nickel ion bioavailability model of the carcinogenic potential of nickel-containing substances in the lung. Crit Rev Toxicol. 2011 Feb; 41(2):142-74.
    View in: PubMed
    Score: 0.017
  14. Goodman JE, Dodge DG, Bailey LA. A framework for assessing causality and adverse effects in humans with a case study of sulfur dioxide. Regul Toxicol Pharmacol. 2010 Nov; 58(2):308-22.
    View in: PubMed
    Score: 0.017
  15. Goodman JE. Neurodevelopmental effects of decabromodiphenyl ether (BDE-209) and implications for the reference dose. Regul Toxicol Pharmacol. 2009 Jun; 54(1):91-104.
    View in: PubMed
    Score: 0.015
  16. Goodman JE, Prueitt RL, Dodge DG, Thakali S. Carcinogenicity assessment of water-soluble nickel compounds. Crit Rev Toxicol. 2009; 39(5):365-417.
    View in: PubMed
    Score: 0.015
  17. Goodman JE, Gaylor D, Beyer LA, Rhomberg LR, Beck BD. Effects of MTBE on the reported incidence of Leydig cell tumors in Sprague-Dawley rats: range of possible Poly-3 results. Regul Toxicol Pharmacol. 2008 Apr; 50(3):273-84.
    View in: PubMed
    Score: 0.014
  18. Lynch HN, Goodman JE, Tabony JA, Rhomberg LR. Systematic comparison of study quality criteria. Regul Toxicol Pharmacol. 2016 Apr; 76:187-98.
    View in: PubMed
    Score: 0.006
  19. Lamb JC, Boffetta P, Foster WG, Goodman JE, Hentz KL, Rhomberg LR, Staveley J, Swaen G, Van Der Kraak G, Williams AL. Comments on the opinions published by Bergman et al. (2015) on Critical Comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals (Lamb et al., 2014). Regul Toxicol Pharmacol. 2015 Dec; 73(3):754-7.
    View in: PubMed
    Score: 0.006
  20. Lamb JC, Boffetta P, Foster WG, Goodman JE, Hentz KL, Rhomberg LR, Staveley J, Swaen G, Van Der Kraak G, Williams AL. Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals - 2012. Regul Toxicol Pharmacol. 2014 Jun; 69(1):22-40.
    View in: PubMed
    Score: 0.005
  21. Bailey LA, Goodman JE, Beck BD. Proposal for a revised Reference Concentration (RfC) for manganese based on recent epidemiological studies. Regul Toxicol Pharmacol. 2009 Dec; 55(3):330-9.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)